Abstract:Chaperone-mediated autophagy (CMA) is a selective degradative process for cytosolic proteins that contributes to the maintenance of proteostasis. The signaling mechanisms that control CMA are not fully understood but might involve response to stress conditions including oxidative stress. Considering the role of CMA in redoxtasis and proteostasis, we sought to determine if the transcription factor NFE2L2/NRF2 (nuclear factor, erythroid derived 2, like 2) has an impact on CMA modulation. In this work, we identified and validated 2 NFE2L2 binding sequences in the LAMP2 gene and demonstrated in several human and mouse cell types that NFE2L2 deficiency and overexpression was linked to reduced and increased LAMP2A levels, respectively. Accordingly, lysosomal LAMP2A levels were drastically reduced in nfe2l2-knockout hepatocytes, which also displayed a marked decrease in CMA activity. Oxidant challenge with paraquat or hydrogen peroxide, or pharmacological activation of NFE2L2 with sulforaphane or dimethyl fumarate also increased LAMP2A levels and CMA activity. Overall, our study identifies for the first time basal and inducible regulation of LAMP2A, and consequently CMA activity, by NFE2L2.ABBREVIATIONS: ACTB: actin, beta, ARE: antioxidant response element; ATG5: autophagy related 5; BACH1: BTB domain and CNC homolog 1; ChIP: chromatin immunoprecipitation; CMA: chaperone-mediated autophagy; DHE: dihydroethidium; DMF: dimethyl fumarate; ENCODE: Encyclopedia of DNA elements at the University of California, Santa Cruz; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GBA: glucosylceramidase beta; GFP: green fluorescent protein; HMOX1: heme oxygenase 1; H<sub>2</sub>O<sub>2</sub>: hydrogen peroxide; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; KEAP1: kelch like ECH associated protein 1; LAMP2A: lysosomal associated membrane protein 2A; LAMP2B: lysosomal associated membrane protein 2B; LAMP2C: lysosomal associated membrane protein 2C; LAMP1: lysosomal associated membrane protein 1; MAFF: MAF bZIP transcription factor F; MAFK: MAF bZIP transcription factor K; NFE2L2/NRF2: nuclear factor, erythroid derived 2, like 2; NQO1: NAD(P)H quinone dehydrogenase 1; PQ: paraquat; PI: protease inhibitors; qRT-PCR: quantitative real-time polymerase chain reaction; RNASE: ribonuclease A family member; SFN: sulforaphane; SQSTM1/p62: sequestosome 1; TBP: TATA-box binding protein.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how the transcription factor NFE2L2/NRF2 affects chaperone - mediated autophagy (CMA) by regulating lysosome - associated membrane protein 2A (LAMP2A). Specifically, the researchers want to verify whether NFE2L2 can directly regulate the expression of LAMP2A and whether this regulation will affect the activity of CMA, especially under oxidative stress conditions. ### Research Background Chaperone - mediated autophagy (CMA) is a selective protein degradation process, which is crucial for maintaining intracellular protein homeostasis. CMA recognizes and transports cytoplasmic proteins with specific motifs into lysosomes for degradation through the LAMP2A receptor on the lysosome surface. Although the role of CMA in response to various stress conditions has been understood to some extent, its regulatory mechanism is still not fully clear, especially the response mechanism to oxidative stress. ### Research Objectives 1. **Determine whether NFE2L2/NRF2 directly regulates the expression of LAMP2A**: - Through bioinformatics analysis and experimental verification, confirm whether NFE2L2 binds to the antioxidant response element (ARE) in the LAMP2 gene. - Through gene over - expression and knockdown experiments, observe the effect of NFE2L2 on the expression level of LAMP2A. 2. **Explore the effect of NFE2L2 on CMA activity**: - Treat cells with oxidative stress inducers (such as paraquat or hydrogen peroxide) and observe whether NFE2L2 can enhance the expression of LAMP2A and CMA activity. - Use pharmacological activators (such as sulforaphane or dimethyl fumarate) to activate NFE2L2 and further verify its effect on LAMP2A and CMA. 3. **Verify whether the regulation of CMA by NFE2L2 is independent of other autophagy pathways**: - Test the regulatory effect of NFE2L2 on CMA in cells with defective macroautophagy to exclude the interference of other autophagy pathways. ### Main Findings - **NFE2L2 binds to and activates ARE in the LAMP2 gene**: - Through ChIP - qPCR experiments, it was verified that NFE2L2 binds to two functional AREs (ARE1 and ARE2) in the LAMP2 gene. - Over - expression of NFE2L2 significantly increased the expression of LAMP2A, while knockdown of NFE2L2 decreased the expression of LAMP2A. - **NFE2L2 regulates CMA activity**: - Under oxidative stress conditions, the activation of NFE2L2 significantly increased the expression of LAMP2A and CMA activity. - Pharmacological activation of NFE2L2 can also enhance the expression of LAMP2A and CMA activity. - **The regulation of CMA by NFE2L2 is independent of macroautophagy**: - In cells with defective macroautophagy, NFE2L2 can still activate CMA, indicating that its regulation of CMA is independent. ### Conclusion This study reveals for the first time the molecular mechanism by which NFE2L2 affects CMA activity through transcriptional regulation of LAMP2A expression. This finding not only enhances the understanding of the regulatory mechanism of CMA, but also provides a new strategy for increasing CMA activity by activating NFE2L2 and then clearing damaged proteins. This has important application prospects in aging and age - related pathological conditions.

Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

Identification of an Adaptor Protein That Facilitates Nrf2-Keap1 Complex Formation and Modulates Antioxidant Response.

Chaperone‐mediated autophagy degrades Keap1 and promotes Nrf2‐mediated antioxidative response

Serine ubiquitination of SQSTM1 regulates NFE2L2-dependent redox homeostasis

AMPK-Mediated Phosphorylation of Nrf2 at S374/S408/S433 Favors Its βTrCP2-Mediated Degradation in KEAP1-Deficient Cells

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

Synergism and Antagonism of Two Distinct, but Confused, Nrf1 Factors in Integral Regulation of the Nuclear-to-Mitochondrial Respiratory and Antioxidant Transcription Networks.

Loss of ubiquitinated protein autophagy is compensated by persistent cnc/NFE2L2/Nrf2 antioxidant responses

Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses

Targetome analysis of chaperone-mediated autophagy in cancer cells

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Chaperone-mediated autophagy protects against hyperglycemic stress

Metabolic stress induces a double-positive feedback loop between AMPK and SQSTM1/p62 conferring dual activation of AMPK and NFE2L2/NRF2 to synergize antioxidant defense

Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity

P62 Links Autophagy and Nrf2 Signaling

Calorie restriction and calorie-restriction mimetics activate chaperone-mediated autophagy

Chaperone-mediated autophagy controls the turnover of E3 ubiquitin ligase MARCHF5 and regulates mitochondrial dynamics

AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3

The Paf1 Complex Transcriptionally Regulates the Mitochondrial-Anchored Protein Atg32 Leading to Activation of Mitophagy.

Regulation of NRF2 by Post-translational Modifications